Cell-delivery therapeutics for liver regeneration

Advanced Drug Delivery Reviews

Volumn 62, Issue 7-8, 2010, Pages 814-826

  Zhang, Wenxia ^a   Tucker Kellogg, Lisa ^a,b   Narmada, B C ^c   Venkatraman, Lakshmi ^a   Chang, Shi ^a,d   Lu, Yin ^b   Tan, Nancy ^e   White, Jacob K ^b,g   Jia, Ruirui ^a   Bhowmick, Sourav Saha ^b,h   Shen, Shali ^a   Dewey, C Forbes ^b,f   Yu, Hanry ^a,b,c,i,j  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE MIT ALLIANCE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e GLENEAGLES HOSPITAL   (Singapore)

^f USA   (United States)

^g Department of Electrical Engineering and Computer Science   (United States)

^h NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

ⁱ AGENCY FOR SCIENCE   (Singapore)

^j SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

more..

Author keywords

Cell transplantation; Delivery vehicles; Encapsulation; Hepatocytes; Liver regeneration; Scaffolds; Stem cells; Systems Biology; Xenogenic cells

Indexed keywords

CELL TRANSPLANTATION; DELIVERY VEHICLE; DELIVERY VEHICLES; HEPATOCYTES; LIVER REGENERATION; SYSTEMS BIOLOGY;

CYTOLOGY; DISEASE CONTROL; LIVER; SCAFFOLDS; TRANSPLANTATION (SURGICAL);

STEM CELLS;

ALGINIC ACID; CHITOSAN; COLLAGEN; CYTOKINE; GALACTOSE; POLYLYSINE; POLYVINYL ALCOHOL; TISSUE SCAFFOLD;

APOPTOSIS; CELL COUNT; CELL ENCAPSULATION; CELL IMMORTALIZATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELL TYPE; DISEASE SEVERITY; DNA MODIFICATION; EMBRYONIC STEM CELL; ENGRAFTMENT; FETUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC ENCEPHALOPATHY; HUMAN; HYDROGEL; KIDNEY PARENCHYMA; LIVER CELL; LIVER DISEASE; LIVER FAILURE; LIVER REGENERATION; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MESENCHYMAL STEM CELL TRANSPLANTATION; MONKEY; MULTIPOTENT STEM CELL; NONHUMAN; PERITONEUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT; REVIEW; SPLEEN; STEM CELL; STEM CELL TRANSPLANTATION; STIMULUS RESPONSE; SWINE; TREATMENT OUTCOME; VASCULARIZATION; XENOGRAFT;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; HEPATOCYTES; HUMANS; LIVER DISEASES; LIVER REGENERATION; SEVERITY OF ILLNESS INDEX; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 77953685065     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2010.02.005     Document Type: Review

References (172)

1. Demetriou A.A., Brown R.S., Busuttil R.W., Fair J., McGuire B.M., et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 2004, 239:660-667. discussion 667-670.
2. Chen M.F., Hwang T.L., Hung C.F. Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography. Ann. Surg. 1991, 213:227-229.
3. Fontana R.J. Acute liver failure including acetaminophen overdose. Med. Clin. North Am. 2008, 92:761-794. viii.
4. Fallowfield J.A., Kendall T.J., Iredale J.P. Reversal of fibrosis: no longer a pipe dream?. Clin. Liver Dis. 2006, 10:481-497. viii.
5. Gallegos-Orozco J.F., Vargas H.E. Liver transplantation: from Child to MELD. Med. Clin. North Am. 2009, 93:931-950. ix.
6. Phua J., Lee K.H. Liver support devices. Curr. Opin. Crit. Care 2008, 14:208-215.
7. Karp S.J. Clinical implications of advances in the basic science of liver repair and regeneration. Am. J. Transplant. 2009, 9:1973-1980.
8. Sgroi A., Serre-Beinier V., Morel P., Buhler L. What clinical alternatives to whole liver transplantation?. Current status of artificial devices and hepatocyte transplantation. Transplantation 2009, 87:457-466.
9. Mito M., Ebata H., Kusano M., Onishi T., Saito T., et al. Morphology and function of isolated hepatocytes transplanted into rat spleen. Transplantation 1979, 28:499-505.
10. Bilir B.M., Guinette D., Karrer F., Kumpe D.A., Krysl J., et al. Hepatocyte transplantation in acute liver failure. Liver Transpl. 2000, 6:32-40.
11. Habibullah C.M., Syed I.H., Qamar A., Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994, 58:951-952.
12. Mito M., Kusano M., Kawaura Y. Hepatocyte transplantation in man. Transplant. Proc. 1992, 24:3052-3053.
13. Schneider A., Attaran M., Meier P.N., Strassburg C., Manns M.P., et al. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation 2006, 82:1115-1116.
14. Strom S.C., Fisher R.A., Thompson M.T., Sanyal A.J., Cole P.E., et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997, 63:559-569.
15. Haridass D., Yuan Q., Becker P.D., Cantz T., Iken M., et al. Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am. J. Pathol. 2009, 175:1483-1492.
16. Wilson J.M. Round two for liver gene therapy. Nat. Genet. 1996, 12:232-233.
17. Christophi C., Harun N., Fifis T. Liver regeneration and tumor stimulation - a review of cytokine and angiogenic factors. J. Gastrointest. Surg. 2008, 12:966-980.
18. Nagasue N., Yukaya H., Ogawa Y., Kohno H., Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann. Surg. 1987, 206:30-39.
19. Schoen Smith J.M., Lautt W.W. The role of prostaglandins in triggering the liver regeneration cascade. Nitric Oxide 2005, 13:111-117.
20. Russell W.E., Coffey R.J., Ouellette A.J., Moses H.L. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl Acad. Sci. USA 1988, 85:5126-5130.
21. Gressner A.M., Lahme B., Mannherz H.G., Polzar B. TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J. Hepatol. 1997, 26:1079-1092.
22. Taub R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 2004, 5:836-847.
23. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83:835-870.
24. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005, 115:209-218.
25. Jiang W., Hiscox S., Matsumoto K., Nakamura T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit. Rev. Oncol. Hematol. 1999, 29:209-248.
26. Lee H.S., Huang A.M., Huang G.T., Yang P.M., Chen P.J., et al. Hepatocyte growth factor stimulates the growth and activates mitogen-activated protein kinase in human hepatoma cells. J. Biomed. Sci. 1998, 5:180-184.
27. Granot E., Boros P., Miller C.M. Differential effect of hepatocyte growth factor and tumor growth factor-beta on early release of vascular endothelial growth factor from HepG2 cells: possible implications in post-transplant liver regeneration. Transplant. Proc. 2001, 33:2926-2928.
28. Monacci W.T., Merrill M.J., Oldfield E.H. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 1993, 264:C995-C1002.
29. Saitou Y., Shiraki K., Yamaguchi Y., Nakano T., Mizuno S., et al. Serum vascular endothelial growth factor-receptor 1 during liver regeneration. J. Hepatol. 2004, 41:170-171.
30. Carpenter B., Lin Y., Stoll S., Raffai R.L., McCuskey R., et al. VEGF is crucial for the hepatic vascular development required for lipoprotein uptake. Development 2005, 132:3293-3303.
31. Uno M., Kurita S., Misu H., Ando H., Ota T., et al. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Hepatology 2008, 48:109-118.
32. Yang S.S., Huang C.C., Chen J.R., Chiu C.L., Shieh M.J., et al. Effects of ethanol on antioxidant capacity in isolated rat hepatocytes. World J. Gastroenterol. 2005, 11:7272-7276.
33. Makowka L., Falk R.E., Rotstein L.E., Falk J.A., Nossal N., et al. Cellular transplantation in the treatment of experimental hepatic failure. Science 1980, 210:901-903.
34. Makowka L., Rotstein L.E., Falk R.E., Falk J.A., Zuk R., et al. Allogeneic and xenogeneic hepatocyte transplantation. Transplant. Proc. 1981, 13:855-859.
35. Makowka L., Rotstein L.E., Falk R.E., Falk J.A., Zuk R., et al. Studies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation. 1. Can. J. Surg. 1981, 24:39-44.
36. Leask A. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc. Res. 2007, 74:207-212.
37. Gupta N., Su X., Popov B., Lee J.W., Serikov V., et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol. 2007, 179:1855-1863.
38. Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993, 122:103-111.
39. van Poll D., Parekkadan B., Cho C.H., Berthiaume F., Nahmias Y., et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008, 47:1634-1643.
40. Fiegel H.C., Kneser U., Kluth D., Metzger R., Till H., et al. Development of hepatic tissue engineering. Pediatr. Surg. Int. 2009, 25:667-673.
41. Chia S.M., Leong K.W., Li J., Xu X., Zeng K., et al. Hepatocyte encapsulation for enhanced cellular functions. Tissue Eng. 2000, 6:481-495.
42. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 1998, 338:1422-1426.
43. Horslen S.P., McCowan T.C., Goertzen T.C., Warkentin P.I., Cai H.B., et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 2003, 111:1262-1267.
44. Martinez-Hernandez A., Amenta P.S. The hepatic extracellular matrix. II. Ontogenesis, regeneration and cirrhosis. Virchows Arch. A Pathol. Anat. Histopathol. 1993, 423:77-84.
45. Venkatraman L., Yu H., Bhowmick S.S., Dewey C.F., Tucker-Kellogg L. The Steady States and Dynamics of Urokinase-mediated Plasmin Activation. Pac. Symp. Biocomput. 2010, 190-200.
46. Sgroi A., Serre-Beinier V., Morel P., Buhler L. What clinical alternatives to whole liver transplantation: current status of artificial devices and hepatocyte transplantation. Transplantation 2009, 87:457-466.
47. Terry C., Hughes R.D. An optimised method for cryopreservation of human hepatocytes. Methods Mol. Biol. 2009, 481:25-34.
48. Hay D.C., Fletcher J., Payne C., Terrace J.D., Gallagher R.C., et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12301-12306.
49. Meindl-Beinker N.M., Dooley S. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis. J. Gastroenterol. Hepatol. 2008, 23(Suppl 1):S122-S127.
50. Watanabe H., Hata M., Terada N., Ueda H., Yamada N., et al. Transdifferentiation into biliary ductular cells of hepatocytes transplanted into the spleen. Pathology 2008, 40:272-276.
51. Zeisberg M., Shah A.A., Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 2005, 280:8094-8100.
52. Zeisberg M., Yang C., Martino M., Duncan M.B., Rieder F., et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 2007, 282:23337-23347.
53. Lehec S.C., Hughes R.D., Mitry R.R., Graver M.A., Verma A., et al. Experience of microbiological screening of human hepatocytes for clinical transplantation. Cell Transplant. 2009.
54. Blei A.T. Selection for acute liver failure: have we got it right?. Liver Transpl. 2005, 11:S30-S34.
55. Riordan S.M., Williams R. Treatment of hepatic encephalopathy. N. Engl. J. Med. 1997, 337:473-479.
56. Khan A.A., Habeeb A., Parveen N., Naseem B., Babu R.P., et al. Peritoneal transplantation of human fetal hepatocytes for the treatment of acute fatty liver of pregnancy: a case report. Trop. Gastroenterol. 2004, 25:141-143.
57. Kobayashi N., Noguchi H., Watanabe T., Matsumura T., Totsugawa T., et al. Establishment of a tightly regulated human cell line for the development of hepatocyte transplantation. Hum. Cell 2000, 13:7-13.
58. Strom S.C., Fisher R.A., Rubinstein W.S., Barranger J.A., Towbin R.B., et al. Transplantation of human hepatocytes. Transplant. Proc. 1997, 29:2103-2106.
59. Dalgetty D.M., Medine C.N., Iredale J.P., Hay D.C. Progress and future challenges in stem cell-derived liver technologies. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297:G241-G248.
60. Zhao Q., Ren H., Zhu D., Han Z. Stem/progenitor cells in liver injury repair and regeneration. Biol. Cell 2009, 101:557-571.
61. Weber A., Groyer-Picard M.T., Franco D., Dagher I. Hepatocyte transplantation in animal models. Liver Transpl. 2009, 15:7-14.
62. Pi L., Oh S.H., Shupe T., Petersen B.E. Role of connective tissue growth factor in oval cell response during liver regeneration after 2-AAF/PHx in rats. Gastroenterology 2005, 128:2077-2088.
63. Lemire J.M., Shiojiri N., Fausto N. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by d-galactosamine. Am. J. Pathol. 1991, 139:535-552.
64. Wang X., Foster M., Al-Dhalimy M., Lagasse E., Finegold M., et al. The origin and liver repopulating capacity of murine oval cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(Suppl 1):11881-11888.
65. Yovchev M.I., Grozdanov P.N., Zhou H., Racherla H., Guha C., et al. Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 2008, 47:636-647.
66. Wu C.X., Zou Q., Zhu Z.Y., Gao Y.T., Wang Y.J. Intrahepatic transplantation of hepatic oval cells for fulminant hepatic failure in rats. World J. Gastroenterol. 2009, 15:1506-1511.
67. Cai J., Zhao Y., Liu Y., Ye F., Song Z., et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007, 45:1229-1239.
68. Teratani T., Yamamoto H., Aoyagi K., Sasaki H., Asari A., et al. Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 2005, 41:836-846.
69. Kumashiro Y., Asahina K., Ozeki R., Shimizu-Saito K., Tanaka Y., et al. Enrichment of hepatocytes differentiated from mouse embryonic stem cells as a transplantable source. Transplantation 2005, 79:550-557.
70. Zemel R., Bachmatov L., Ad-El D., Tur-Kaspa R. Abstracts of the 43rd Annual Meeting of the European Association for the Study of the Liver, April 23-27, 2008, Milan, Italy. J. Hepatol. 2008, 48(Suppl 2):S200-S201.
71. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J. Gastroenterol. Hepatol. 2009, 24:70-77.
72. Tsai P.C., Fu T.W., Chen Y.M., Ko T.L., Chen T.H., et al. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl. 2009, 15:484-495.
73. Malhi H., Irani A.N., Gagandeep S., Gupta S. Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes. J. Cell Sci. 2002, 115:2679-2688.
74. Oertel M., Menthena A., Chen Y.Q., Teisner B., Jensen C.H., et al. Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology 2008, 134:823-832.
75. Sandhu J.S., Petkov P.M., Dabeva M.D., Shafritz D.A. Stem cell properties and repopulation of the rat liver by fetal liver epithelial progenitor cells. Am. J. Pathol. 2001, 159:1323-1334.
76. Yokoyama Y., Nagino M., Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J. Surg. 2007, 31:367-374.
77. Anjos-Afonso F., Siapati E.K., Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell Sci. 2004, 117:5655-5664.
78. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000, 6:1229-1234.
79. Parekkadan B., van Poll D., Suganuma K., Carter E.A., Berthiaume F., et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE 2007, 2:e941.
80. Alison M.R., Poulsom R., Jeffery R., Dhillon A.P., Quaglia A., et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000, 406:257.
81. Korbling M., Katz R.L., Khanna A., Ruifrok A.C., Rondon G., et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N. Engl. J. Med. 2002, 346:738-746.
82. Theise N.D., Nimmakayalu M., Gardner R., Illei P.B., Morgan G., et al. Liver from bone marrow in humans. Hepatology 2000, 32:11-16.
83. Xu D., Alipio Z., Fink L.M., Adcock D.M., Yang J., et al. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc. Natl. Acad. Sci. U S A 2009, 106:808-813.
84. Chen S.S., Fitzgerald W., Zimmerberg J., Kleinman H.K., Margolis L. Cell-cell and cell-extracellular matrix interactions regulate embryonic stem cell differentiation. Stem Cells 2007, 25:553-561.
85. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
86. Zeisberg M., Kramer K., Sindhi N., Sarkar P., Upton M., et al. De-differentiation of primary human hepatocytes depends on the composition of specialized liver basement membrane. Mol. Cell. Biochem. 2006, 283:181-189.
87. Benoist S., Sarkis R., Barbu V., Honiger J., Baudrimont M., et al. Survival and functions of encapsulated porcine hepatocytes after allotransplantation or xenotransplantation without immunosuppression. Surgery 2001, 129:606-616.
88. Nagata H., Ito M., Cai J., Edge A.S., Platt J.L., et al. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology 2003, 124:422-431.
89. Nagata H., Nishitai R., Shirota C., Zhang J.L., Koch C.A., et al. Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology 2007, 132:321-329.
90. Levy M.F., Crippin J., Sutton S., Netto G., McCormack J., et al. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation 2000, 69:272-280.
91. Kobayashi N., Fujiwara T., Westerman K.A., Inoue Y., Sakaguchi M., et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000, 287:1258-1262.
92. Fox I.J., Chowdhury N.R., Gupta S., Kondapalli R., Schilsky M.L., et al. Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer. Hepatology 1995, 21:837-846.
93. Takahashi M., Deb N.J., Kawashita Y., Lee S.W., Furgueil J., et al. A novel strategy for in vivo expansion of transplanted hepatocytes using preparative hepatic irradiation and FasL-induced hepatocellular apoptosis. Gene Ther. 2003, 10:304-313.
94. Cai J., Ito M., Nagata H., Westerman K.A., Lafleur D., et al. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Hepatology 2002, 36:386-394.
95. Kienle K., Rentsch M., Muller T., Engelhard N., Vogel M., et al. Expression of BCL-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and reperfusion in rat liver transplantation. Transplant. Proc. 2005, 37:439-441.
96. Wang J., Li W., Min J., Ou Q., Chen J., et al. Intrasplenic transplantation of allogeneic hepatocytes modified by BCL-2 gene protects rats from acute liver failure. Transplant. Proc. 2004, 36:2924-2926.
97. Guha C., Deb N.J., Sappal B.S., Ghosh S.S., Roy-Chowdhury N., et al. Amplification of engrafted hepatocytes by preparative manipulation of the host liver. Artif. Organs 2001, 25:522-528.
98. Guha C., Parashar B., Deb N.J., Sharma A., Gorla G.R., et al. Liver irradiation: a potential preparative regimen for hepatocyte transplantation. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49:451-457.
99. Zhou H., Yamanouchi K., Liu L., Jiang J., Mohan S., et al. A new paradigm for tissue regeneration: preparative irradiation for cell-based therapies as an alternative to organ transplantation. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66:S98-S99.
100. Schurr A., Reid K.H., Tseng M.T., West C., Rigor B.M. Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res. 1986, 374:244.
101. Jin C., Zhang P.J., Wu X.M., Zhou B., Li Y., et al. Impact of hypoxic preconditioning on apoptosis and its possible mechanism in orthotopic liver autotransplantation in rats. Hepatobiliary Pancreat. Dis. Int. 2009, 8:40-45.
102. Wu Y.-M., Gupta S. Hepatic Preconditioning for Transplanted Cell Engraftment and Proliferation. Hepatocyte Transplantation 2009, 1-10. Humana Press. R.D.H. Anil Dhawan (Ed.).
103. Davis M.W., Vacanti J.P. Toward development of an implantable tissue engineered liver. Biomaterials 1996, 17:365-372.
104. Mooney D., Hansen L., Vacanti J., Langer R., Farmer S., et al. Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol 1992, 151:497-505.
105. Bissell D.M., Choun M.O. The role of extracellular matrix in normal liver. Scand. J. Gastroenterol. Suppl. 1988, 151:1-7.
106. Vacanti J.P., Morse M.A., Saltzman W.M., Domb A.J., Perez-Atayde A., et al. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J. Pediatr. Surg. 1988, 23:3-9.
107. Demetriou A.A., Levenson S.M., Novikoff P.M., Novikoff A.B., Chowdhury N.R., et al. Survival, organization, and function of microcarrier-attached hepatocytes transplanted in rats. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:7475-7479.
108. Demetriou A.A., Whiting J.F., Feldman D., Levenson S.M., Chowdhury N.R., et al. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science 1986, 233:1190-1192.
109. Justice B.A., Badr N.A., Felder R.A. 3D cell culture opens new dimensions in cell-based assays. Drug Discov. Today 2009, 14:102-107.
110. Cho C.S., Seo S.J., Park I.K., Kim S.H., Kim T.H., et al. Galactose-carrying polymers as extracellular matrices for liver tissue engineering. Biomaterials 2006, 27:576-585.
111. Weigel P.H., Schmell E., Lee Y.C., Roseman S. Specific adhesion of rat hepatocytes to beta-galactosides linked to polyacrylamide gels. J. Biol. Chem. 1978, 253:330-333.
112. Du Y., Chia S.-m., Han R., Chang S., Tang H., et al. 3D hepatocyte monolayer on hybrid RGD/galactose substratum. Biomaterials 2006, 27:5669-5680.
113. Du Y., Han R., Ng S., Ni J., Sun W., et al. Identification and characterization of a novel prespheroid 3-dimensional hepatocyte monolayer on galactosylated substratum. Tissue Eng. 2007, 13:1455-1468.
114. Lu H.-F., Lim W.S., Wang J., Tang Z.-Q., Zhang P.-C., et al. Galactosylated PVDF membrane promotes hepatocyte attachment and functional maintenance. Biomaterials 2003, 24:4893-4903.
115. Lei P., Padmashali R.M., Andreadis S.T. Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 2009, 30:3790-3799.
116. Gwak S.J., Choi D., Paik S.S., Lee E.Y., Lees K.S., et al. Stable hepatocyte transplantation using fibrin matrix. Biotechnol. Lett. 2004, 26:505-508.
117. Park K.H., Na K., Kim S.W., Jung S.Y., Chung H.M. Phenotype of hepatocyte spheroids behavior within thermo-sensitive poly(NiPAAm-co-PEG-g-GRGDS) hydrogel as a cell delivery vehicle. Biotechnol. Lett. 2005, 27:1081-1086.
118. Abbott A. Cell culture: biology's new dimension. Nature 2003, 424:870-872.
119. Kinasiewicz A., Dudzinski K., Chwojnowski A., Werynski A., Kawiak J. Three-dimensional culture of hepatocytes on spongy polyethersulfone membrane developed for cell transplantation. Transplant. Proc. 2007, 39:2914-2916.
120. Kneser U., Kaufmann P.M., Fiegel H.C., Pollok J.M., Kluth D., et al. Heterotopic hepatocyte transplantation utilizing pancreatic islet cotransplantation for hepatotrophic stimulation: morphologic and morphometric evaluation. Pediatr. Surg. Int. 1999, 15:168-174.
121. Mooney D.J., Sano K., Kaufmann P.M., Majahod K., Schloo B., et al. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J. Biomed. Mater. Res. 1997, 37:413-420.
122. Aoki T., Umehara Y., Ferraresso C., Sugiyama N., Middleton Y., et al. Intrasplenic transplantation of encapsulated cells: a novel approach to cell therapy. Cell Transplant. 2002, 11:553-561.
123. Aoki T., Jin Z., Nishino N., Kato H., Shimizu Y., et al. Intrasplenic transplantation of encapsulated hepatocytes decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats. Transplantation 2005, 79:783-790.
124. Gaserod O., Sannes A., Skjak-Braek G. Microcapsules of alginate-chitosan. II. A study of capsule stability and permeability. Biomaterials 1999, 20:773-783.
125. Rokstad A.M., Holtan S., Strand B., Steinkjer B., Ryan L., et al. Microencapsulation of cells producing therapeutic proteins: optimizing cell growth and secretion. Cell Transplant. 2002, 11:313-324.
126. Haque T., Chen H., Ouyang W., Martoni C., Lawuyi B., et al. Investigation of a new microcapsule membrane combining alginate, chitosan, polyethylene glycol and poly-l-lysine for cell transplantation applications. Int. J. Artif. Organs 2005, 28:631-637.
127. Haque T., Chen H., Ouyang W., Martoni C., Lawuyi B., et al. In vitro study of alginate-chitosan microcapsules: an alternative to liver cell transplants for the treatment of liver failure. Biotechnol. Lett. 2005, 27:317-322.
128. Chia S.M., Wan A.C., Quek C.H., Mao H.Q., Xu X., et al. Multi-layered microcapsules for cell encapsulation. Biomaterials 2002, 23:849-856.
129. Yin C., Mien Chia S., Hoon Quek C., Yu H., Zhuo R.-X., et al. Microcapsules with improved mechanical stability for hepatocyte culture. Biomaterials 2003, 24:1771-1780.
130. Wen L., Grude P., Conti F., Honiger J., Capeau J., et al. Suppression of humoral immunization against encapsulated xenogeneic hepatocytes and prolongation of their function by 2-week cyclosporine treatment in the rat. Surgery 2000, 127:301-308.
131. Mikos A.G., Sarakinos G., Lyman M.D., Ingber D.E., Vacanti J.P., et al. Prevascularization of porous biodegradable polymers. Biotechnol. Bioeng. 1993, 42:716-723.
132. Mooney D.J., Kaufmann P.M., Sano K., McNamara K.M., Vacanti J.P., et al. Transplantation of hepatocytes using porous, biodegradable sponges. Transplant. Proc. 1994, 26:3425-3426.
133. Murphy W.L., Peters M.C., Kohn D.H., Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 2000, 21:2521-2527.
134. Fontaine M., Schloo B., Jenkins R., Uyama S., Hansen L., et al. Human hepatocyte isolation and transplantation into an athymic rat, using prevascularized cell polymer constructs. J. Pediatr. Surg. 1995, 30:56-60.
135. Kedem A., Perets A., Gamlieli-Bonshtein I., Dvir-Ginzberg M., Mizrahi S., et al. Vascular endothelial growth factor-releasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng. 2005, 11:715-722.
136. Smith M.K., Riddle K.W., Mooney D.J. Delivery of hepatotrophic factors fails to enhance longer-term survival of subcutaneously transplanted hepatocytes. Tissue Eng. 2006, 12:235-244.
137. Mayer C., Gruber H.J., Landl E.M., Pailer S., Scharnagl H., et al. Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3- and C/EBP-dependent fashion. Int. J. Clin. Pharmacol. Ther. 2007, 45:319-327.
138. Karp J.M., Langer R. Development and therapeutic applications of advanced biomaterials. Curr. Opin. Biotechnol. 2007, 18:454-459.
139. Murua A., Portero A., Orive G., Hernández R.M., de Castro M., et al. Cell microencapsulation technology: towards clinical application. J. Control. Release 2008, 132:76-83.
140. Gunsalus J.R., Brady D.A., Coulter S.M., Gray B.M., Edge A.S. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation. Nat. Med. 1997, 3:48-53.
141. Overturf K., Al-Dhalimy M., Tanguay R., Brantly M., Ou C.N., et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat. Genet. 1996, 12:266-273.
142. Gordon M.Y., Levicar N., Pai M., Bachellier P., Dimarakis I., et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006, 24:1822-1830.
143. Ponder K.P., Gupta S., Leland F., Darlington G., Finegold M., et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:1217-1221.
144. Nishio R., Nakayama M., Ikekita M., Watanabe Y. Auxiliary liver organ formation by implantation of spleen-encapsulated hepatocytes. Tissue Eng. 2006, 12:2565-2572.
145. Kay M.A., Baley P., Rothenberg S., Leland F., Fleming L., et al. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:89-93.
146. Kobayashi N., Ito M., Nakamura J., Cai J., Gao C., et al. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 2000, 31:851-857.
147. Weglarz T.C., Degen J.L., Sandgren E.P. Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes. Am. J. Pathol. 2000, 157:1963-1974.
148. Nagata H., Ito M., Shirota C., Edge A., McCowan T.C., et al. Route of hepatocyte delivery affects hepatocyte engraftment in the spleen. Transplantation 2003, 76:732-734.
149. Gupta S., Lee C.D., Vemuru R.P., Bhargava K.K. 111Indium labeling of hepatocytes for analysis of short-term biodistribution of transplanted cells. Hepatology 1994, 19:750-757.
150. Vroemen J.P., Buurman W.A., Heirwegh K.P., van der Linden C.J., Kootstra G. Hepatocyte transplantation for enzyme deficiency disease in congenic rats. Transplantation 1986, 42:130-135.
151. Ohashi K., Marion P.L., Nakai H., Meuse L., Cullen J.M., et al. Sustained survival of human hepatocytes in mice: a model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat. Med. 2000, 6:327-331.
152. Ohashi K., Kay M.A., Yokoyama T., Kuge H., Kanehiro H., et al. Stability and repeat regeneration potential of the engineered liver tissues under the kidney capsule in mice. Cell Transplant. 2005, 14:621-627.
153. Uyama S., Kaufmann P.M., Takeda T., Vacanti J.P. Delivery of whole liver-equivalent hepatocyte mass using polymer devices and hepatotrophic stimulation. Transplantation 1993, 55:932-935.
154. Fox I.J., Chowdhury J.R. Hepatocyte transplantation. Am. J. Transplant. 2004, 4(Suppl 6):7-13.
155. Baldini E., Cursio R., De Sousa G., Margara A., Honiger J., et al. Peritoneal implantation of cryopreserved encapsulated porcine hepatocytes in rats without immunosuppression: viability and function. Transplant. Proc. 2008, 40:2049-2052.
156. Jirtle R.L., Michalopoulos G. Enhancement of the clonability of adult parenchymal hepatocytes with the liver tumor promoter phenobarbital. Carcinogenesis 1986, 7:1813-1817.
157. Gebhardt R., Jirtle R., Moorman A.F., Lamers W.H., Michalopoulos G. Induction of glutamine synthetase and transient co-expression with carbamoylphosphate synthetase in hepatocytes transplanted into fat pads of syngeneic hosts. Histochemistry 1989, 92:337-342.
158. Gupta S., Vemuru R.P., Lee C.D., Yerneni P.R., Aragona E., et al. Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: implications for hepatic gene therapy. Hum. Gene Ther. 1994, 5:959-967.
159. Gupta S., Gorla G.R., Irani A.N. Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies. J. Hepatol. 1999, 30:162-170.
160. Gupta S., Chowdhary J.R. Hepatocyte transplantation: back to the future. Hepatology 1992, 15:156-162.
161. Stepniak E., Ricci R., Eferl R., Sumara G., Sumara I., et al. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev. 2006, 20:2306-2314.
162. Enns G.M., Millan M.T. Cell-based therapies for metabolic liver disease. Mol. Genet. Metab. 2008, 95:3-10.
163. Meyburg J., Das A.M., Hoerster F., Lindner M., Kriegbaum H., et al. One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 2009, 87:636-641.
164. Puppi J., Tan N., Mitry R.R., Hughes R.D., Lehec S., et al. Hepatocyte transplantation followed by auxiliary liver transplantation-a novel treatment for ornithine transcarbamylase deficiency. Am. J. Transplant. 2008, 8:452-457.
165. Stephenne X., Najimi M., Smets F., Reding R., de Ville de Goyet J., et al. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am. J. Transplant. 2005, 5:2058-2061.
166. Sokal E.M., Smets F., Bourgois A., Van Maldergem L., Buts J.P., et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 2003, 76:735-738.
167. Dhawan A., Mitry R.R., Hughes R.D., Lehec S., Terry C., et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 2004, 78:1812-1814.
168. Muraca M., Gerunda G., Neri D., Vilei M.T., Granato A., et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002, 359:317-318.
169. Allen K.J., Soriano H.E. Liver cell transplantation: the road to clinical application. J. Lab. Clin. Med. 2001, 138:298-312.
170. Dhawan A., Mitry R.R., Hughes R.D. Hepatocyte transplantation for liver-based metabolic disorders. J. Inherit. Metab. Dis. 2006, 29:431-435.
171. Nguyen T.H., Mainot S., Lainas P., Groyer-Picard M.T., Franco D., et al. Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors. Curr. Gene Ther. 2009, 9:136-149.
172. Horslen S.P., Fox I.J. Hepatocyte transplantation. Transplantation 2004, 77:1481-1486.